West Pharmaceutical Services EBITDA 2010-2024 | WST

West Pharmaceutical Services annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • West Pharmaceutical Services EBITDA for the quarter ending March 31, 2024 was $0.158B, a 15.25% decline year-over-year.
  • West Pharmaceutical Services EBITDA for the twelve months ending March 31, 2024 was $0.785B, a 4.55% decline year-over-year.
  • West Pharmaceutical Services 2023 annual EBITDA was $0.813B, a 4.83% decline from 2022.
  • West Pharmaceutical Services 2022 annual EBITDA was $0.855B, a 2.29% decline from 2021.
  • West Pharmaceutical Services 2021 annual EBITDA was $0.875B, a 69.5% increase from 2020.
West Pharmaceutical Services Annual EBITDA
(Millions of US $)
2023 $813
2022 $855
2021 $875
2020 $516
2019 $400
2018 $345
2017 $323
2016 $286
2015 $219
2014 $272
2013 $248
2012 $212
2011 $185
2010 $164
2009 $166
West Pharmaceutical Services Quarterly EBITDA
(Millions of US $)
2024-03-31 $158
2023-12-31 $197
2023-09-30 $213
2023-06-30 $217
2023-03-31 $187
2022-12-31 $161
2022-09-30 $216
2022-06-30 $259
2022-03-31 $219
2021-12-31 $218
2021-09-30 $211
2021-06-30 $240
2021-03-31 $205
2020-12-31 $145
2020-09-30 $128
2020-06-30 $130
2020-03-31 $114
2019-12-31 $104
2019-09-30 $93
2019-06-30 $107
2019-03-31 $96
2018-12-31 $92
2018-09-30 $87
2018-06-30 $86
2018-03-31 $80
2017-12-31 $85
2017-09-30 $88
2017-06-30 $66
2017-03-31 $84
2016-12-31 $76
2016-09-30 $74
2016-06-30 $84
2016-03-31 $52
2015-12-31 $69
2015-09-30 $19
2015-06-30 $61
2015-03-31 $70
2014-12-31 $67
2014-09-30 $67
2014-06-30 $77
2014-03-31 $61
2013-12-31 $59
2013-09-30 $62
2013-06-30 $63
2013-03-31 $64
2012-12-31 $52
2012-09-30 $46
2012-06-30 $54
2012-03-31 $60
2011-12-31 $45
2011-09-30 $45
2011-06-30 $47
2011-03-31 $48
2010-12-31 $26
2010-09-30 $44
2010-06-30 $48
2010-03-31 $47
2009-12-31 $40
2009-09-30 $44
2009-06-30 $45
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00